Evotec SE
EVO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001412558
No open-market purchases or sales by Evotec SE insiders were filed in the last 90 days; 34 institutions reported holding it in 13F filings for Q2 2026, worth $9.07M in total; no superinvestor holds it.
Other share classesEVOTF
13F holders, Q1 2025
Institutional positions in Evotec SE as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 25
- −1 vs. Q4 2024
- Shares held
- 9.10M
- +224.1K (+2.5%) vs. Q4 2024
- Total value
- $30.4M
- −$6.53M (−17.7%) vs. Q4 2024
- New holders
- 5
- 5 more added
- Sold out
- 6
- 9 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EVO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 34 | $9.07M |
| Q1 2026 | 46 | $20.3M |
| Q4 2025 | 44 | $30.4M |
| Q3 2025 | 37 | $35.9M |
| Q2 2025 | 37 | $40.5M |
| Q1 2025 | 25 | $30.4M |
| Q4 2024 | 26 | $36.9M |
| Q3 2024 | 24 | $29.6M |
| Q2 2024 | 28 | $35.0M |
| Q1 2024 | 20 | $38.7M |
| Q4 2023 | 28 | $66.5M |
| Q3 2023 | 24 | $12.0M |
| Q2 2023 | 20 | $15.4M |
| Q1 2023 | 19 | $14.5M |
| Q4 2022 | 22 | $21.1M |
| Q3 2022 | 22 | $43.5M |
| Q2 2022 | 21 | $57.3M |
| Q1 2022 | 22 | $83.3M |
| Q4 2021 | 20 | $157.3M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Evotec SE; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Mubadala Investment Co PJSC | 4,597,701 | $15.4M | 0.09% | 00.0% | Unchanged |
| Wellington Management Group LLP | 1,903,401 | $6.36M | 0.00% | −396,504−17.2% | Reduced |
| BlackRock, Inc. | 1,522,664 | $5.09M | 0.00% | +78,425+5.4% | Added |
| DCF Advisers, LLC | 751,579 | $2.51M | 1.35% | +521,708+227.0% | Added |
| Morgan Stanley | 88,041 | $294.1K | 0.00% | −37,880−30.1% | Reduced |
| Abc Arbitrage SA | 77,919 | $260.2K | 0.05% | +77,919 | New |
| Tower Research Capital LLC (TRC) | 41,185 | $137.6K | 0.00% | +41,185 | New |
| Lighthouse Investment Partners, LLC | 37,545 | $125.4K | 0.01% | −2,258−5.7% | Reduced |
| Fore Capital, LLC | 17,005 | $56.8K | 0.07% | +17,005 | New |
| UBS Group AG | 13,620 | $45.5K | 0.00% | +9,914+267.5% | Added |
| CSS LLC | 12,100 | $40.4K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 11,868 | $39.6K | 0.00% | −49,250−80.6% | Reduced |
| BNP Paribas Arbitrage, SA | 7,400 | $24.7K | 0.00% | +800+12.1% | Added |
| Quadrant Capital Group LLC | 5,300 | $17.7K | 0.00% | −502−8.7% | Reduced |
| Bank of America Corp | 3,888 | $13.0K | 0.00% | −8,940−69.7% | Reduced |
| Signaturefd, LLC | 3,052 | $10.2K | 0.00% | −890−22.6% | Reduced |
| Briaud Financial Planning, Inc | 2,160 | $7.00K | 0.00% | 00.0% | Unchanged |
| CBIZ Investment Advisory Services, LLC | 840 | $2.81K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 490 | $1.64K | 0.00% | −15−3.0% | Reduced |
| US Bancorp | 250 | $835 | 0.00% | 00.0% | Unchanged |
| Accent Capital Management, LLC | 200 | $668 | 0.00% | −212−51.5% | Reduced |
| Jones Financial Companies LLLP | 150 | $497 | 0.00% | +150 | New |
| SBI Securities Co., Ltd. | 99 | $331 | 0.00% | +5+5.3% | Added |
| Principal Securities, Inc. | 42 | $175 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 4 | $13 | 0.00% | +4 | New |
| JustInvest LLC | 0 | $0 | 0.00% | −12,836−100.0% | Sold out |
| Mariner, LLC | 0 | $0 | 0.00% | −10,500−100.0% | Sold out |
| Optiver Holding B.V. | 0 | $0 | 0.00% | −2,543−100.0% | Sold out |
| Lindbrook Capital, LLC | 0 | $0 | 0.00% | −536−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −98−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −68−100.0% | Sold out |